What are the contraindications for digoxin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Digoxin Contraindications

Digoxin is absolutely contraindicated in patients with ventricular fibrillation, second- or third-degree atrioventricular block without a permanent pacemaker, pre-excitation syndromes (such as Wolff-Parkinson-White syndrome with atrial fibrillation), and known hypersensitivity to digoxin or other digitalis preparations. 1, 2, 3

Absolute Contraindications

Cardiac Conduction Disorders

  • Second- or third-degree heart block without a permanent pacemaker is an absolute contraindication because digoxin further depresses AV nodal conduction and can precipitate complete heart block or asystole. 2, 3, 4
  • Patients with suspected sick sinus syndrome should be approached with extreme caution, as digoxin can worsen sinus node dysfunction. 2

Pre-Excitation Syndromes

  • Wolff-Parkinson-White syndrome and other pre-excitation syndromes represent absolute contraindications, particularly when atrial fibrillation or atrial flutter is present, because digoxin can shorten the refractory period of the accessory pathway and precipitate ventricular fibrillation. 2, 3, 4

Hypersensitivity

  • Known hypersensitivity to digoxin or any digitalis preparation is an absolute contraindication. 1
  • Previous evidence of digoxin intolerance constitutes a contraindication to reinitiating therapy. 2, 3

Life-Threatening Arrhythmias

  • Ventricular fibrillation is an absolute contraindication per FDA labeling. 1

Relative Contraindications and High-Risk Scenarios

Electrolyte Disturbances

  • Uncorrected hypokalemia, hypomagnesemia, or hypercalcemia dramatically increase the risk of digoxin toxicity even at therapeutic serum concentrations, because these electrolyte abnormalities sensitize the myocardium to digoxin's effects. 3, 5, 4
  • Serum potassium should be maintained between 4.0–5.5 mEq/L before initiating digoxin. 3, 5

Metabolic and Endocrine Disorders

  • Hypothyroidism increases sensitivity to digoxin and lowers dosing requirements, raising toxicity risk. 3, 5
  • Severe renal impairment (creatinine clearance < 30 mL/min) requires extreme caution, as digoxin is primarily renally excreted and accumulation is inevitable without dose reduction. 3, 4

Acute Cardiac Conditions

  • Acute myocardial infarction represents a relative contraindication due to increased myocardial irritability. 3
  • Decompensated heart failure with hemodynamic instability or cardiogenic shock should prompt consideration of alternative therapies, as digoxin is not indicated for acute stabilization. 3, 6

Drug Interactions Creating Contraindications

  • Digoxin should be used with extreme caution or avoided when combined with other drugs that depress AV nodal function (amiodarone, beta-blockers, non-dihydropyridine calcium channel blockers) unless carefully monitored, as additive AV blockade can occur. 2, 3, 6

Common Clinical Pitfalls

  • Do not assume "therapeutic" digoxin levels exclude toxicity—toxicity can occur at concentrations below 2 ng/mL when electrolyte abnormalities, renal dysfunction, hypothyroidism, or drug interactions coexist. 3, 5, 7
  • Never administer digoxin to patients with hypokalemia (potassium < 4.0 mEq/L) without first correcting the deficiency, as this dramatically increases the risk of life-threatening arrhythmias. 3, 5
  • Avoid loading doses in stable outpatients with heart failure or atrial fibrillation, as they provide no mortality or morbidity benefit and increase toxicity risk. 2, 3, 4
  • Recognize that digoxin monotherapy is ineffective for rate control during exercise in atrial fibrillation due to its vagally-mediated mechanism; combination with a beta-blocker is required for adequate rate control. 2, 3, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Effective Doses of Digoxin for Heart Failure and Atrial Fibrillation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Digoxin Dosing and Management for Adults with Atrial Fibrillation or Heart Failure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Digoxin Toxicity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Digoxin remains useful in the management of chronic heart failure.

The Medical clinics of North America, 2003

Research

Digoxin is still useful, but is still causing toxicity.

Cleveland Clinic journal of medicine, 2024

Related Questions

What is Digoxin used for?
How should digoxin be dosed (loading and maintenance) and monitored for rate control in atrial fibrillation or symptom relief in systolic heart failure, considering renal function, age, weight, serum electrolytes, and interacting medications?
What are the guidelines for using digoxin (Digitalis) in patients with atrial fibrillation or heart failure, particularly those with impaired renal (kidney) function?
What is the recommended heart rate monitoring and dosing strategy for patients with a history of heart conditions, such as atrial fibrillation or heart failure, taking digoxin?
What is the treatment approach for an adult patient with a history of cardiovascular disease and atrial fibrillation or heart failure who is taking digoxin (digitalis glycoside)?
What is the recommended approach to evaluate polyuria?
How should I manage a patient with uncontrolled stage 2 hypertension (blood pressure 180/110 mm Hg) who is already taking telmisartan 40 mg daily and metoprolol 50 mg daily?
What is the recommended treatment for bacterial vaginosis, including first‑line therapy, alternative regimens, safety in pregnancy, need for partner treatment, and management of recurrence?
Can hemorrhagic symptoms and cytopenias in an adult with essential thrombocythemia be resolved with therapy?
What is the appropriate diagnostic work‑up and initial management for a suspected brain tumor?
A patient 6 days post‑stroke presents with a blood pressure of 220/120 mm Hg while taking oral losartan 50 mg once daily and nicardipine retard (nicardipine) 10 mg twice daily—what immediate (stat) management is required and should the oral antihypertensive regimen be modified?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.